Pegasus Health

Pegasus Health (Charitable) Ltd is a primary care network providing services and support to general practices and the community in Canterbury. As one of the largest Primary Healthcare Organisations (PHO) in New Zealand, our network encompasses over 400,000 enrolled patients, approximately 330 member GPs, 330 practice nurses and nearly 450 staff as well as many other community providers.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HEALTH TECHNOLOGY

KAREO AND PATIENTPOPS COMBINED PLATFORM LEVERAGED BY THE PERDIDO BAY MEDICAL GROUP TO DELIVER INTEGRATED CARE AND GROW BUSINESS

Kareo | April 04, 2022

news image

Dr. Daniel Spriggs, a long-time Kareo user at his former practices, chose to continue using the integrated platform for his new practice the Perdido Bay Medical Group because of its functionality, familiarity, and ease of use. Dr. Spriggs was previously part of other medical groups, and so he needed to develop a new online identity when he opened his new practice. In the first 60 days following implementation, PatientPop’s solution improved the practice’s visibility online garneri...

Read More

FDA WARNS AGAINST MALARIA DRUG'S COVID-19 USE OUTSIDE HOSPITALS

FDA | April 24, 2020

news image

The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems. The decades-old drug has been called a “game changer” by Trump in the fight against the novel coronavirus and anecdotal reports that it may provide some benefit have spurred sales of the drug. Within hours of Trump&rsquo...

Read More

MEDICAL DEVICES

GENEQUANTUM HEALTHCARE'S TWO NEXT GENERATION BIOCONJUGATE DRUGS, GQ1005 AND GQ1007, HAVE BEEN APPROVED FOR CLINICAL TRIALS IN AUSTRALIA

GeneQuantum Healthcare | May 16, 2022

news image

GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...

Read More

HEALTH TECHNOLOGY

AXXESS PARTNERS WITH SURESCRIPTS HEALTH INFORMATION NETWORK

Axxess | December 15, 2020

news image

A new partnership will convey enhanced interoperability for care at home supplier associations utilizing Axxess programming to improve quiet results. Axxess, the main innovation trend-setter for care at home, declared a reconciliation with Surescripts, a cross country wellbeing data network that underpins electronic transmission of drug and clinical data between basically all electronic wellbeing records (EHR) sellers, ...

Read More
news image

HEALTH TECHNOLOGY

KAREO AND PATIENTPOPS COMBINED PLATFORM LEVERAGED BY THE PERDIDO BAY MEDICAL GROUP TO DELIVER INTEGRATED CARE AND GROW BUSINESS

Kareo | April 04, 2022

Dr. Daniel Spriggs, a long-time Kareo user at his former practices, chose to continue using the integrated platform for his new practice the Perdido Bay Medical Group because of its functionality, familiarity, and ease of use. Dr. Spriggs was previously part of other medical groups, and so he needed to develop a new online identity when he opened his new practice. In the first 60 days following implementation, PatientPop’s solution improved the practice’s visibility online garneri...

Read More
news image

FDA WARNS AGAINST MALARIA DRUG'S COVID-19 USE OUTSIDE HOSPITALS

FDA | April 24, 2020

The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems. The decades-old drug has been called a “game changer” by Trump in the fight against the novel coronavirus and anecdotal reports that it may provide some benefit have spurred sales of the drug. Within hours of Trump&rsquo...

Read More
news image

MEDICAL DEVICES

GENEQUANTUM HEALTHCARE'S TWO NEXT GENERATION BIOCONJUGATE DRUGS, GQ1005 AND GQ1007, HAVE BEEN APPROVED FOR CLINICAL TRIALS IN AUSTRALIA

GeneQuantum Healthcare | May 16, 2022

GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...

Read More
news image

HEALTH TECHNOLOGY

AXXESS PARTNERS WITH SURESCRIPTS HEALTH INFORMATION NETWORK

Axxess | December 15, 2020

A new partnership will convey enhanced interoperability for care at home supplier associations utilizing Axxess programming to improve quiet results. Axxess, the main innovation trend-setter for care at home, declared a reconciliation with Surescripts, a cross country wellbeing data network that underpins electronic transmission of drug and clinical data between basically all electronic wellbeing records (EHR) sellers, ...

Read More